Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity

BioSerenity, developer of solutions dedicated to personalized patient continuous care, raises €65 million, including €50 million in Series B equity financing led by Dassault Systèmes …

More Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity Videos